Please assess the completion status of the following clinical trial:

Trial Title: Telemedicine for Improving Outcome in Inner City Patient Population With Hypercapneic Respiratory Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients \> 18 years of age~* Evidence of hypercapnia (PCO2 ≥ 45mmHg) secondary to COPD-OSA overlap, OHS, Neuromuscular disease / weakness~* Requiring NIV / NIPPV outpatient~* Ability to operate a smart device / tablet~* Informed consent~Exclusion Criteria:~* Non-English or Non-Spanish- speaking (device videos and surveys are available in English or Spanish only)~* Patients unable to give consent~* Pregnant women~* Prisoners~* Patients \<18 years of age~* Patient already on NIPPV/ CPAP at home and compliant on therapy~* Significant non-pulmonary conditions (CHF with EF \< 40%), Pulmonary hypertension with PASP\> 60 mmGH, severe valvular heart disease, end-stage renal disease or end-stage liver disease.~* Patients without health insurance~* Residing out of state (Pennsylvania)~* Patients with current or history of drug / narcotic dependence

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vivify + EMS (Type: ACTIVE_COMPARATOR): This arm will have the Telemedicine kits and get scheduled EMS home visits. The subjects will complete daily biometrics / surveys / care plans through the telemedicine kit, as specified in the activity schedule Apart from the tablet device, EMS home visits will be scheduled on Day 7, Day 21 and Day 42 from discharge. During these home visits, the EM personnel will perform a check of the NIV/NIPPV device. They are able to adjust pressures according to your Pulmonologist / Sleep doctor's prescription, and troubleshoot any issues with the mask, the humidifier, etc. They will also measure End-tidal CO2 via nasal cannula.
- Vivify Only (Type: ACTIVE_COMPARATOR): This group will receive the telemedicine tablet and kit, with the same protocol as defined above.~No EMS home visits will be set up

Based on this trial design, predict the completion outcome and termination type (if applicable).